Chronic rhinosinusitis with nasal polyps is among our most challenging diagnoses to treat, because these patients essentially have chronic, lifelong inflammation that needs chronic, lifelong treatment, says Benjamin Bleier, a sinus surgeon at the Massachusetts Eye and Ear Hospital and an assistant professor of otolaryngology at Harvard Medical School.

Some of the inflammation in chronic rhinosinusitis with nasal polyps seems to arise when the nasal lining overexpresses P-glycoprotein (a protein pump), leading to over-secretion of inflammatory cytokines. Verapamil blocks P-glycoprotein and, in some patients with chronic rhinosinusitis and nasal polyps, dramatically improves symptom scores, according to a new study.

While the study involving 18 patients is too small to confirm efficacy, the improvement in several outcome measures suggest that verapamil should be assessed further at a higher dose. “We observed no significant side-effects at the doses we used, and we were very encouraged by the results of this first step,” says Dr Bleier.

(J Allergy Clin Immunol DOI: 10.1016/j.jaci.2016.11.014)


NICE recommends Tremfya

NICE has approved Tremfya (guselkumab) for the treatment of adults with moderate to severe plaque psoriasis

Paracetamol, pregnancy and language

Exposure to paracetamol during pregnancy seems to increase the risk of language delay in girls, but not boys

This website is for healthcare professionals only. By clicking "Accept" to hide this message or by clicking into any content on this website, you confirm you are a healthcare professional, consent to accepting cookies in accordance with our Cookie Policy and agree to Pharmacy Magazine’s Terms of Use and Privacy Policy.